Insight Molecular Diagnostics, Inc. (IMDX)
3.76
+0.24
(+6.82%)
USD |
NASDAQ |
Apr 24, 16:00
3.76
0.00 (0.00%)
After-Hours: 20:00
Insight Molecular Diagnostics EPS Diluted (Quarterly) : -0.7159 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| FONAR Corp. | 0.3058 |
| Interpace Biosciences, Inc. | 0.8178 |
| Thermo Fisher Scientific, Inc. | 4.43 |
| XWELL, Inc. | -3.036 |
| Hypha Labs, Inc. | -0.0034 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.96M |
| Revenue (Quarterly) | 1.139M |
| Total Expenses (Quarterly) | 24.09M |
| Enterprise Value | 112.14M |
| Gross Profit Margin (Quarterly) | -4.13% |
| Profit Margin (Quarterly) | -2.02K% |
| Earnings Yield | -43.05% |
| Normalized Earnings Yield | -30.99 |